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AbstrAct
Papua New Guinea (PNG) is a culturally, environmentally 
and ethnically diverse country of 7.3 million people 
experiencing rapid economic development and social 
change. Such development is typically associated with an 
increase in non-communicable disease (NCD) risk factors.
Aim To establish the prevalence of NCD risk factors 
in three different regions across PNG in order to guide 
appropriate prevention and control measures.
Methods A cross-sectional survey was undertaken with 
randomly selected adults (15–65 years), stratified by age 
and sex recruited from the general population of integrated 
Health and Demographic Surveillance Sites in West Hiri 
(periurban), Asaro (rural highland) and Karkar Island (rural 
island), PNG. A modified WHO STEPS risk factor survey was 
administered along with anthropometric and biochemical 
measures on study participants.
Results The prevalence of NCD risk factors was markedly 
different across the three sites. For example, the prevalences 
of current alcohol consumption at 43% (95% CI 35 to 52), 
stress at 46% (95% CI 40 to 52), obesity at 22% (95% 
CI 18 to 28), hypertension at 22% (95% CI 17 to 28), 
elevated levels of cholesterol at 24% (95% CI 19 to 29) and 
haemoglobin A1c at 34% (95% CI 29 to 41) were highest in 
West Hiri relative to the rural areas. However, central obesity 
at 90% (95% CI 86 to 93) and prehypertension at 55% 
(95% CI 42 to 62) were most common in Asaro whereas 
prevalences of smoking, physical inactivity and low high-
density lipoprotein-cholesterol levels at 52% (95% CI 45 
to 59), 34% (95% CI 26 to 42) and 62% (95% CI 56 to 68), 
respectively, were highest in Karkar Island.
Conclusion Adult residents in the three different 
communities are at high risk of developing NCDs, 
especially the West Hiri periurban population. There is 
an urgent need for appropriate multisectoral preventive 
interventions and improved health services. Improved 
monitoring and control of NCD risk factors is also needed 
in all regions across PNG.
IntroductIon
Non-communicable diseases (NCDs) are 
the leading cause of death and morbidity 
throughout the world, with the greatest burden 
in low and middle-income countries (LMICs), 
where nearly 80% of NCD-related deaths and 
82% of all NCD premature deaths occur.1 2 
According to the WHO, approximately 46% of 
all NCD-related deaths in 2012 were due to 
cardiovascular diseases (CVDs), followed by 
cancers (22%), respiratory disease (11%) 
and diabetes (4%).2 Furthermore, the global 
burden of diseases study reported that CVDs, 
such as ischaemic heart disease and stroke, 
continue to be among the top three leading 
causes of death globally.3
Papua New Guinea (PNG) is a country of 
approximately 7.3 million people located 
in the Western Pacific and renowned for its 
Key questions
What is already known about this topic?
 ► The prevalence of non-communicable diseases 
(NCDs) and their risk factors in Papua New Guinea is 
increasing but varied based on ethnicity, lifestyle and 
the living environment. 
 ► Current prevalence of NCD and their risk factors is 
unknown in West Hiri, a community impacted by a 
gas mining project and two rural non-project impact 
areas, Asaro and Karkar Island.
What are the new findings?
 ► Our study provided a baseline prevalence of NCD risk 
factors in West Hiri and an up-to-date prevalence of 
NCD risk factors in Asaro and Karkar Island. 
 ► Results suggest that socioeconomic and nutrition 
transition may  be under  way in all sites but more 
apparent in the West Hiri population.
Recommendations for policy
 ► The results strongly suggest an introduction of 
control measures particularly in West Hiri and 
continuous monitoring across the country.
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environmental, cultural and biological diversity.4 5 PNG is 
categorised as a lower-middle-income country according 
to the World Bank criteria6 and is experiencing rapid 
economic growth as a result of large-scale mineral and gas 
resource developments.7 Rapid economic growth in other 
LMICs has been associated with an epidemiological tran-
sition characterised by an increasing prevalence of NCDs 
and their risk factors with an often concomitant reduc-
tion in infectious disease.8 9 While infectious diseases such 
as acute respiratory tract infections, tuberculosis, malaria 
and HIV/AIDS are the leading causes of morbidity and 
mortality in PNG,10 the available evidence suggests this 
pattern is changing among those adult populations with 
longer exposure to modernisation. The latter is leading to 
rapid lifestyle changes associated with increases in CVD and 
diabetes.11–23 In addition, PNG still has high rates of child-
hood stunting,24–26 a risk factor for NCDs in adulthood.27 
The cost of treating and managing a growing NCD burden 
is already posing a substantial challenge to the country’s 
economy, particularly given the challenges of the PNG 
health system, which include deteriorating infrastructure, 
poor governance, an ageing and inadequate healthcare 
workforce, and a paucity of specialist services.28
NCDs and associated risk factors, such as smoking, 
excessive alcohol consumption, stress, unhealthy diet, 
physical inactivity, obesity, hypertension and abnormal 
lipid profiles, have not been well investigated in PNG. 
Several small studies conducted among specific popu-
lations over the past few decades have identified an 
increasing, or relatively high, prevalence of NCDs and 
NCD risk factors.18 19 21 29–34 They suggest variations in 
NCD risks within PNG based on lifestyle and living envi-
ronment18 19 21 29 and on ethnic origin.33 34 Furthermore, 
a lack of physical activity, particularly among urban 
migrants, increases the risk of acquiring an NCD19 21; 
and urban dwellers of any ethnic origin in PNG are at 
higher risk of CVDs and diabetes relative to their rural 
peers.19 21 31 32 35 The 2007/2008 PNG NCD Risk Factor 
STEPS study reported that the majority of surveyed adults 
were at risk of developing NCDs.36 Since the STEPS 
survey, there has been limited up-to-date information 
on the prevalence of NCD risk factors across the diverse 
populations of PNG. Major resource developments have 
occurred since the STEPS survey last decade, and there 
is a need for a comprehensive NCD risk survey during 
this period of development. Currently in PNG, there 
is no systematic monitoring of NCD prevalence, or the 
associated risk factors, to measure the anticipated epide-
miological transition across the country.
The present study was undertaken during the construc-
tion phase of a large-scale gas development which was 
projected to more than double the gross domestic product 
of PNG.7 Our study was designed to provide baseline prev-
alence data on NCD risk factors in the initial years of a 
gas project impact site (West Hiri) and in two non-project 
impact sites (Asaro and Karkar). It was also anticipated 
that the study findings would provide up-to-date NCD 
prevalence data to help the national government plan 
services and develop cost-effective interventions. In this 
paper, we describe the methods used and present the 
initial findings for NCD risk factors in a survey of three 
different sociodemographic populations of PNG.
Methods
study design
Between April 2013 and October 2014, we undertook 
a cross-sectional, community-based survey in three 
integrated Health and Demography Surveillance Sites 
(iHDSS) set up by the PNG Institute of Medical Research 
(PNGIMR).37 38 The study included the completion 
of a standardised questionnaire based on the WHO 
STEPwise approach for NCD Risk Factor surveillance,39 
which included physical measurements and biological 
sample collection from randomly selected adults (aged 
15–65 years) from the general population of each iHDSS. 
Information on health service utilisation was not collected 
but can be incorporated and reported in future NCD risk 
factor surveys and analysis. Further cross-sectional surveys 
of NCD risk factors and prevalence are planned for each 
iHDSS in the future, pending additional funding.
sample size and selection
Using a simple random sampling procedure, a total of 
300 adult participants, stratified by sex and age (15–29, 
30–44, 45–65 years), were sought from each iHDSS (ie, 
100 participants from each of the three age groups, 50 
male and 50 female) and invited to take part in the study. 
The sampling frame was a full population census of the 
adult general population of each iHDSS. The target 
sample size (n=900) was estimated to confer 80% power 
to detect a 10% absolute difference in the proportion of 
most risk factors for all ages combined between each site 
or a 10% relative difference in means at the 0.05 signifi-
cance level (two sided).
study sites
The three iHDSS were West Hiri (Central Province), 
Asaro (Eastern Highlands Province) and Karkar Island 
(Madang Province) as shown in figure 1. The West Hiri 
iHDSS comprises villages with a baseline (2011) popu-
lation of 11 531 people37 of Austronesian ancestry,40 
distributed along a 20–30 km stretch of coastline north-
west of Port Moresby, the national capital and largest 
city in PNG. The West Hiri site was selected because it 
represents a periurban population affected by a large 
gas development project. The villages surround a gas 
processing plant and their close proximity to Port 
Moresby has changed the traditional diet, social cohe-
sion and skilled activities such as fishing and gardening.41 
The Asaro iHDSS comprises a baseline (2011) popula-
tion of 10 034 people37 38 of non-Austronesian ancestry,40 
situated 40–45 km north-east of Goroka, the largest 
town in the Eastern highlands. People in Asaro are 
primarily subsistence farmers, but earn cash through 
smallholder production of coffee, employment on plan-
tations and selling garden produce.42 The Karkar Island 
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iHDSS comprises a rural baseline population of 18 623 
people37 38 of both Austronesian and non-Austronesian 
ancestries43 located 30 km off the northern coastline of 
Madang Province. Most adult residents of Karkar Island 
are subsistence farmers and/or unskilled labourers. The 
island’s soil is fertile and large plantations produce the 
island’s main exports of cocoa and coconut and provide 
most of the local employment opportunities.37 38 The 
majority of PNG’s population live in rural areas and 
about 87% of the adult population is engaged in both 
subsistence farming and commercial activities.5 44 There-
fore, Asaro and Karkar Island populations reflect rural 
communities that largely depend on subsistence farming 
and cash cropping in highlands and lowlands/coastal 
PNG, respectively.
study measures and collection methods
Interviews were conducted at participants’ homes or 
community health facilities. Eligibility criteria included 
recorded residence within the respective iHDSS and 
ages between 15 and 65 years at the time of survey. 
Women were excluded if they were pregnant at the time 
of recruitment. All survey forms and procedures were 
completed at a single time point by the survey team.
Interviews
The NCD study tool was adapted from the WHO STEPS 
NCD Risk Factor Survey.39 Question domains included: 
participant demographics; self-reported health status; 
self-reported stress; consumption of vegetables, fruits, 
protein, fried food, salt and sugar; food security; tobacco, 
betel nut and alcohol use; physical activity; participant 
history of NCD and/or associated treatments. The self-re-
ported stress, diet and physical activity questions were 
all developed specifically for this study and for use with 
PNG-based populations. The questionnaire was available 
in English and Tok Pisin, the local creole language that 
the interviewers could speak fluently. All questionnaires 
were piloted extensively prior to survey commencement.
Measurement
Weight in kilograms (kg) was measured using a Seca digital 
scale to 100 g precision and height (cm) to 0.1 cm preci-
sion using a Seca Leicester stadiometer. Participants were 
able to wear light clothes, but no shoes. A Seca figure 
finder constant tension tape was used to measure to 0.1 cm 
precision the hip (level of widest part of the buttocks) and 
waist circumferences (midpoint between lower rib and iliac 
crest) in centimetre (cm). After participants had rested 
for 10 min in a sitting position their blood pressures (BP) 
were measured using an OMRON T9P digital automated 
sphygmomanometer. Three readings were taken at 1 min 
intervals using appropriate cuff sizes and the average of the 
three readings was used for the analysis.
biochemical measures
Capillary blood from a finger prick was taken on the spot 
and analysed for haemoglobin levels using a HemoCue 
device (HemoCue Hb201+, Angelholm, Sweden). If 
haemoglobin levels were above 6 g/dL, a further 30 mL 
of non-fasting venous blood was collected. The initial 
10 mL of blood was collected using EDTA vacutainers 
and analysed for haemoglobin A1c (HbA1c) levels using 
the DCA Vantage Analyzer from Siemens Healthcare 
Australia and New Zealand. The remaining 20 mL was 
collected using two 10 mL serum vacutainers which were 
aliquoted and stored initially at −20°C in each study 
site before they were transported to the Port Moresby 
PNGIMR laboratory. The serum samples were analysed 
for lipids (cholesterol and high-density lipoprotein-cho-
lesterol (HDL-C)) using Vitros 250/350 Biochemistry 
System from Ortho Clinical Diagnostics, in batches 
within a month of collection. After analysis, aliquots of 
plasma, serum and cell pallets were stored initially at 
−20°C freezer in Port Moresby before archiving in −80°C 
freezer for long-term storage.
Measurement of ncd risk factors
Daily tobacco smoking was defined as current tobacco 
smoking on a daily basis and current alcohol consump-
tion was defined as alcohol consumption within the last 
30 days. Betel nut chewing which consists of areca nut, 
betel leaf/bean and slaked lime is widely practised across 
PNG and current use was defined as betel nut chewing 
within the last 30 days. Insufficient physical activity 
was defined as spending less than 75 or 150 min/week 
on vigorous and moderate physical activities, respec-
tively.45 Body mass index (BMI) was calculated as weight 
(kg) divided by height in metres squared (m2). Over-
weight and obesity were defined as BMI ≥25–29.9 kg/
m2 and ≥30 kg/m2, respectively.46 Central obesity in men 
and women was defined as a waist-to-hip ratio ≥0.90 and 
≥0.85 for men and women, respectively.47 Hypertension 
was defined as the average of the three systolic and/or 
diastolic BP readings of ≥140 mm Hg and/or ≥90 mm 
Figure 1 Map of Papua New Guinea showing the 
three survey sites: West Hiri (periurban) and two rural 
communities, Asaro and Karkar Island.
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Hg, respectively or diagnosed hypertensive cases on 
antihypertensive drugs.48 Prehypertension was defined 
as systolic and diastolic BPs of >120–139.9 mm Hg and 
>80–89.9 mm Hg, respectively.48 Elevated cholesterol 
levels were defined as cholesterol levels of >6.2 mm/L. 
Low HDL-C levels were defined as <1 mmol/L 
and <1.3 mmol/L for men and women, respectively.49 50 
Participants with elevated HbA1c were defined to have 
HbA1c levels ≥5.7%. In accordance with the Amer-
ican Diabetes Association Standards of Medical Care in 
Diabetes, diabetes mellitus type 2 (DMT2) was diagnosed 
if the participant was on antidiabetic drugs or when the 
participants’ HbA1c was ≥6.5%.51
data analysis
STATA/SE V.13.0 (StataCorp LP) was used for all data 
analyses. Analysis was limited to descriptive summaries 
of all major measures and inferential analyses to assess 
intersite differences for major outcome variables using 
Pearson’s χ2 test, Fisher’s exact test and one-way analysis 
of variance where appropriate. Risk factor prevalence 
with 95% CI for binary variables and the means with SD 
for continuous variables were examined by study site. 
More detailed analyses exploring relationships between 
specified risk factors and NCDs as well as lung function, 
haemoglobin and urine microalbumin levels, detailed 
dietary and physical activity results will be presented in 
subsequent publications. The totals (No.) presented 
in all tables are denominators unless otherwise stated. 
Tobacco, betel nut and alcohol questions were not origi-
nally included in the NCD questionnaire, and as a result, 
these questions were not asked of all participants. To 
address missing values, available case analysis was used.
ethics approval
The study was given ethical approval by the PNGIMR 
Institutional Review Board (IRB) and the PNG Medical 
Research Advisory Committee (MRAC) (IRB No. 1208, 
23 March 2012; MRAC No. 12.34, November 2012). 
Written, informed consent was obtained prior to study 
participation. Any participant identified with hyperten-
sion, DMT2, hyperlipidaemia or chronic obstructive 
pulmonary disease was referred to the local general 
hospital for further investigation and management.
results
Of the total 900 randomly selected participants, 785 
(87.2%) adults participated in the survey. Here we 
present the results of the 772 participants who completed 
the survey and had their blood collected. Table 1 pres-
ents the demographic characteristics of the overall study 
population and by iHDSS. The three study sites were 
comparable in terms of participants’ age and sex. Overall, 
33% of study participants received an education past 
primary school level and only 16% were engaged in paid 
employment. Across the sites, West Hiri participants were 
better educated and more likely to be in paid employ-
ment compared with participants from Asaro and Karkar 
Island, where the majority were subsistence farmers/cash 
croppers.
Participants were asked about their weekly consump-
tion of vegetables, fruits, protein, sugar, salt and fried 
food. As shown in table 2, 65% and 58% of all partic-
ipants reported the consumption of root and green 
vegetables, respectively, for at least 5 days of the week but 
this varied across sites (p<0.001). Residents of West Hiri 
reported the lowest percentage of root vegetable (17%) 
and greens (14%) consumption; however, they reported 
the highest percentage of fruit (24%) and animal protein 
(canned 52% and fresh 48%) consumption. The addi-
tion of at least 6 teaspoons of sugar in a hot drink daily 
was highest in both Asaro (20%) and West Hiri (20%) 
compared with Karkar Island (11%) (p<0.03). Fried 
food consumption also varied across the sites with Asaro 
participants (43%) recording the highest consumption 
of fried food at home, 5 or more days per week, relative 
to West Hiri (16%) and Karkar Island (0%) (p<0.001). 
The lowest salt consumption was reported by Karkar 
Island participants (22%) compared with those in West 
Hiri and Asaro.
Participants were asked if a health worker had previ-
ously diagnosed them with one or more of a range of 
specified NCDs. Overall, as shown in table 3, very few 
participants reported having received a diagnosis of any 
of the stated conditions and all diagnoses, except hyper-
tension, chronic lung disease and cancer, were from West 
Hiri. Participants from Karkar and Asaro reported the 
least number of NCD diagnoses.
Table 4 presents data on behavioural and clinical NCD 
risk factors. Tobacco smoking was common across all 
three sites but we found significant differences between 
the sites in the type of tobacco smoked. West Hiri partic-
ipants only smoked manufactured tobacco, but Karkar 
Island and Asaro reported higher prevalence of smoking 
home-grown tobacco as compared with manufactured 
tobacco. Prevalence of betel nut use was also high across 
all three sites, although current alcohol consumption 
was comparatively lower, especially in Karkar Island 
(7%). Higher proportions of men than women smoked 
tobacco and drank alcohol. Overall, 32% of participants 
reported currently feeling stressed. The prevalence of 
stress was significantly higher in West Hiri and Asaro 
compared with Karkar Island (p<0.001). The prevalence 
of insufficient physical activity was highest in Karkar 
Island (34%) compared with Asaro (6%) and West Hiri 
(23%) (p<0.001). Overall, 19% and 11% of participants 
were categorised as overweight or obese, respectively. 
There was a statistically significant difference between 
the sites with higher prevalence of overweight (25%) and 
obesity (22%) in West Hiri compared with the other two 
sites (p<0.001). However, Asaro had a higher percentage 
(90%) of participants with central obesity, based on the 
waist-to-hip ratio, than the other two sites and this differ-
ence was statistically significant (p<0.001). There was 
also a statistically significant difference in the prevalence 
of hypertension between the sites, with Karkar Island 
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participants having the lowest prevalence of hyperten-
sion (5%) compared with West Hiri (22%) and Asaro 
(22%) (p<0.001). Higher percentages of elevated choles-
terol (24%) and HbA1c (34%) were observed among 
West Hiri participants compared with Asaro and Karkar.
dIscussIon
The results from our study provide baseline prevalence 
of NCD risk factors in three sites in PNG. Combined 
with earlier data from Asaro and Karkar sites, there is 
evidence of an increase in some key NCD risk factors; 
however, there is substantial variation among the three 
communities due to demographic and socioeconomic 
differences. The NCD risk appears greatest in the peri-
urban site of West Hiri, relative to the rural sites of Asaro 
and Karkar Island. Similar rural-urban differences have 
been seen in other PI nations such as Fiji and Western 
Samoa.52 53 Previous studies found non-Austronesian 
populations to be less susceptible to developing diabetes 
and other NCDs.34 54 The Asaro population of non-Aus-
tronesian origin, however, recorded the highest central 
obesity and prehypertension prevalence, indicating a 
rural population at very high risk of developing CVDs. 
West Hiri, an Austronesian population, as expected, 
had a higher prevalence of CVD and DMT2 risk factors. 
Karkar Island, a mixed Austronesian and non-Austro-
nesian population, had low prevalence of some risk 
factors such as overweight and obesity, hypertension and 
elevated HbA1c levels. It also recorded the highest prev-
alence of tobacco smoking, insufficient physical activity 
and low HDL-C levels, indicating an increased risk for 
developing NCDs.
This is the first NCD study in West Hiri and having a 
diet low in vegetables compared with Asaro and Karkar 
Island reflects limited subsistence farming. However, 
more participants are in paid employment with regular 
income, which may explain the comparatively high 
alcohol and cigarette use and a diet high in sugar, salt 
and animal protein. Its close proximity to Port Moresby 
has resulted in a longer exposure to modernisation and 
the consequent increased risk of developing DMT2 and 
other NCDs.9 32 52 This study provides evidence of an 
Table 1 Demographic characteristics of the participants of the non-communicable disease study by iHDSS. The values are 
numbers and percentages (95% CI)
Overall
(n=772)
West Hiri
(n=266)
Asaro
(n=254)
Karkar Island
(n=252)
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Sex
  Male 361 47 (43 to 50) 114 43 (37 to 49) 130 51 (45 to 58) 117 46 (40 to 53)
  Female 411 53 (50 to 57) 152 57 (51 to 63) 124 49 (43 to 55) 135 54 (48 to 60
Age group (years)
  15–29 216 28 (25 to 31) 73 27 (22 to 33) 69 27 (22 to 33) 74 29 (24 to 35)
  30–44 261 34 (31 to 37) 93 35 (29 to 41) 88 35 (29 to 41) 30 32 (8 to 17)
  45–65 295 38 (35 to 42) 100 38 (32 to 44) 97 38 (32 to 45) 98 39 (33 to 45)
Education
  Primary or lower 519 67 (64 71) 119 45 (39 to 51) 198 78 (72 to 83) 202 80 (75 to 85)
  Some/complete secondary 159 21 (18 to 24) 92 35 (29 to 41) 28 11 (8 to 16) 39 16 (11 to 21)
  Vocational/tertiary 26 3 (2 to 5) 20 8 (5 to 11) 3 1 (0 to 3) 3 1 (0 to 3)
  Don’t know 68 9 (7 to 11) 35 13 (9 to 18) 25 10 (7 to 14) 8 3 (1 to 6)
Employment
  Home duties 157 20 (18 to 23) 92 35 (29 to 41) 15 6 (3 to 10) 50 20 (15 to 25)
  Subsistence/cash cropper 349 45 (42 to 49) 23 9 (6 to 13) 179 71 (64 to 76) 147 58 (52 to 65)
  Paid employment 121 16 (13 to 18) 89 34 (28 to 40) 15 6 (3 to 10) 17 7 (4 to 11)
  Unemployed/retired/student 114 15 (12 to 18) 55 21 (16 to 26) 24 10 (6 to 14) 35 14 (10 to 19)
  Not given 31 4 (3 to 6) 7 3 (1 to 5) 21 8 (5 to 12) 3 1 (0 to 3)
Marital status
  Single/never married 155 20 (17 to 23) 62 23 (18 to 29) 38 15 (11 to 20) 55 22 (17 to 27)
  Married 508 66 (62 to 29) 167 63 (57 to 69) 157 62 (56 to 68) 184 73 (67 to 78)
  Separated/divorced 33 4 (3 to 6) 6 2 (1 to 5) 22 9 (6 to 13) 5 2 (1 to 5)
  Widowed 33 4 (3 to 6) 14 5 (3 to 9) 14 6 (3 to 9) 5 2 (1 to 5)
  Not given 43 6 (4 to 7) 17 6 (4 to 10) 23 9 (6 to 13) 3 1 (0 to 3)
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existing high prevalence of NCD risk factors in the West 
Hiri population. The NCD risk factor burden is expected 
to increase further, especially with the socioeconomic 
transition occurring in this population, which may be 
accelerated due to its Austronesian ancestry and close 
proximity to PNG’s fastest growing city, and through the 
steep increase in local disposable incomes (via salaries, 
wages and royalty payments from the gas project).
The prevalence of daily tobacco smoking in our study 
(41%) is far higher than the 26.3% prevalence reported 
in the 2009/2010 national Household Income and Expen-
diture Survey (HIES),55 yet consistent with the 43.7% and 
47.7% in the 2007/2008 PNG STEPS and Global Youth 
Tobacco Survey, respectively.36 56 Our findings confirm that 
tobacco smoking rates have been high for a long period. 
There are even higher prevalences of current tobacco 
smokers in other Pacific countries, some of which were very 
high as in Kiribati, Wallis and Futuna, Tokelau and Fiji.57 As 
tobacco smoking increases the risk of developing CVDs and 
other NCDs,58 59 our findings suggest public health efforts 
are needed to identify appropriate measures to reduce 
the consumption of both manufactured and home-grown 
tobacco. Increasing tobacco tax has reduced consumption 
of manufactured tobacco elsewhere,60 but may not be 
effective in populations where home-grown tobacco is 
widely used. Accordingly, in addition to WHO’s ‘Best Buy’ 
interventions,61 public awareness campaigns highlighting 
the harmful effects of smoking, inclusive of home-grown 
tobacco, are required throughout PNG.
The prevalence of betel nut chewing was highest in the 
two coastal communities, where it is grown, compared 
with the highlands community of Asaro, and this is 
similar to a 1968 study which showed very high preva-
lence of betel nut chewing in two coastal communities, 
compared with a highlands community whose betel nut 
use was far lower.62 The overall prevalence of betel nut 
chewing is higher than the 2009/2010 national HIES,55 
but supports the 2007/2008 STEPS36 prevalence. Even 
reported prevalences from other countries as Taiwan 
and Malaysian Borneo were lower than the findings 
from our study.63 Chewing of betel nut has been asso-
ciated with oral cancer, elevated glucose and increased 
risk of CVDs.64–67 It is deeply embedded into PNG’s 
social and cultural traditions and is prevalent across the 
country,36 55 62 even among pregnant women.68 There-
fore, it will be important to monitor the impacts of this 
Table 2 Study participants’ self-reported food consumption in a typical week by iHDSS. Values are in numbers and 
percentages (95% CI)
Food consumption
Overall
n=772
West Hiri
n=266
Asaro
n=254
Karkar Island
n=252
p Value*n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Root 
vegetables >5 days/
week†
503 65 (62 to 69) 46 17 (13 to 22) 211 83 (78 to 88) 245 98 (94 to 99) <0.001
Greens >5 days/
week†
451 58 (54 to 62) 36 14 (10 to 18) 168 66 (60 to 72) 247 98 (95 to 99) <0.001
Fruits >5 days/week† 97 13 (10 to 15) 64 24 (19 to 30) 33 13 (9 to 18) 0 0 (0 to 1) <0.001
Fresh protein 5 days/
week†
216 28 (25 to 31) 128 48 (42 to 54) 4 2 (0.4 to 4) 84 33 (28 to 40) <0.001
Canned protein 
5 days/week†
181 23 (21 to 27) 138 52 (46 to 58) 26 10 (7 to 15) 17 7 (4 to 11) <0.001
Teaspoon 
sugar >6 tsp daily
132 17 (15 to 20) 53 20 (15 to 25) 51 20 (15 to 26) 28 11 (8 to 16) 0.026
Sugary drinks 3+ 
days/week‡
43 6 (4 to 7) 34 13 (9 to 17) 9 4 (2 to 7) 0 0 (0 to 1) <0.001
Purchased fried 
food >5 days/week†
18 2 (1 to 4) 4 2 (0 to 4) 14 6 (3 to 9) 0 0 (0 to 1) <0.001
Home fried 
food >5 days/week†
151 20 (17 to 23) 41 16 (11 to 20) 109 43 (37 to 49) 1 0.4 (0 to 2) <0.001
Stock cube 7 days/
week§
5 1 (0 to 2) 2 1 (0.1 to 2.7) 1 0 (0 to 2) 2 1 (0 to 3) 0.377
Salt directly on food 
7 days/week§
361 47 (43 to 50) 162 61 (55 to 67) 144 57 (50 to 63) 55 22 (17 to 27) <0.001
*p Values were obtained by Pearson’s χ2test and Fisher’s exact test where appropriate, †Consumed for at least 5 days in a typical 
week, ‡Consumption of soft drink for at least 3 days in a typical week, §Consumption for 7 days of the week.
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habit and provide appropriate public health messages 
combined with stronger and sustainable measures to 
reduce its use. A betel nut ban has recently been imple-
mented in Port Moresby69 and a robust evaluation should 
be conducted in order to establish the public health 
benefit, if any, from this intervention.
Our study found a higher prevalence of current alcohol 
use among the periurban West Hiri (43%) relative to 
rural Asaro (22%) and Karkar (7%) and this may be due 
to the high employment rate and increased availability of 
cash among the West Hiri population. A similar pattern 
reported in 1977 saw an increased alcohol use among 
men with high social status in the two communities of 
Karkar Island and Lufa.70 However, our results showed 
a similar ‘binge drinking’ pattern (low frequency, high 
volume consumption) across all sites which was a common 
finding among Pacific youths in New Zealand.71 The 
national HIES (9%) and STEPS (15%) survey reported 
lower prevalence of alcohol consumption than our find-
ings. Studies from neighbouring PI nations, however, 
recorded much higher alcohol consumption rates.57 
This binge drinking pattern in PNG previously reported 
to contribute to law and order problems affecting one’s 
health, work and family.72 As such, adoption of appro-
priate measures such as WHO’s ‘best buys’61 is needed 
to control excessive alcohol consumption in the country 
which may include increased tax in the manufacture and 
sale of alcohol, ban on alcohol advertisement and aware-
ness through education.
The findings from our study reveal that one in every 
three participants reported stress. However, there were 
significant differences across the sites, where Karkar 
participants reported the least percentage of stress rela-
tive to West Hiri and Asaro. Karkar participants live on 
an island further away from the nearest town compared 
with West Hiri and Asaro who are closer to towns, relying 
more on cash economy for the purchase of goods and 
services. A recent study identified two major sources of 
stress among PNG women: one is economic and supply 
instability and the other is stress associated with relation-
ships with others.73 Changes associated with urbanisation 
are likely to affect both. Further studies are needed to 
investigate the degree of stress as well as identify the 
stress vulnerable groups faced in PNG.
Our study found a higher prevalence of physical inac-
tivity in both Karkar Island and West Hiri, compared with 
Asaro. The overall prevalence of insufficient physical 
activity is higher than that reported in the STEPS survey. 
PNG has one of the lowest prevalences of physical inac-
tivity in the Pacific region where rates greater than 50% 
in both women and men have been reported.57 Cultur-
ally appropriate interventions are needed to promote 
sufficient physical activity across PNG to help reduce the 
risk of developing NCDs. With towns and urban areas 
becoming unsafe for walking or jogging, most people 
commute only by vehicle,74 pointing to a need for urban 
planners to incorporate safety plans to enable the use of 
public space for leisure activities.T
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Our results showed a higher prevalence of overweight 
and obesity in periurban West Hiri relative to rural Asaro 
and Karkar Island. Norgan in 1995 reported overweight 
and obesity prevalence in Karkar and Lufa communities 
was less than 10%,75 which is lower than our findings. 
In addition, the overall obesity prevalence (11%) in our 
study is higher than that reported in the PNG STEPS 
survey.36 Although the West Hiri obesity rates (22%) are 
comparable to that reported for Port Moresby residents 
(21%), it is lower than that in some neighbouring Pacific 
Islands.35 57 Despite the low prevalence of obesity, espe-
cially in Asaro and Karkar Island, our results showed very 
high prevalence of central obesity (waist-to-hip ratio) 
across all sites, but more so in Asaro. Central obesity, 
based on waist-to-hip ratio, has been reported to substan-
tially increase the risk of CVDs and is a preferred measure 
of obesity for predicting CVD and all-cause deaths.76 77 
The high prevalence of central obesity in Asaro indicates 
a different propensity for fat distribution to West Hiri. 
This finding further indicates the standard BMI thresh-
olds may not be suitable for use in PNG, as has also been 
suggested for other ethnic groups in the Asia Pacific 
region.46 Some countries have introduced taxes on 
unhealthy food and beverages to reduce their consump-
tion.78 Health promotion via media, education in schools 
and workplaces as that in New Zealand79 may also help 
reduce overweight and obesity prevalence. PNG may 
need to consider adopting such initiatives to help reduce 
and control the availability and sales of high sugar, salt 
and fat content foods in the country.
Other CVD risk factors, such as elevated BP and hyper-
lipidaemia, were higher across the three sites in our 
study compared with the earlier PNG STEPS survey. 
High rates of prehypertension (55%) in the Asaro popu-
lation are concerning as studies conducted between the 
1950s and 1980s in the highlands population showed low 
levels of elevated BP.80–82 According to previous studies in 
Asaro, the prevalence of hypertension was14 83 lower than 
our findings (22%). Similarly, in the 1960s–1980s hyper-
tension was absent or very low in Karkar as elsewhere in 
the country.14 84–86 However, our results showed increased 
prevalence of both prehypertension (38%) and hyper-
tension (5%) among the Karkar population. Over the 
last two decades, hypertension has been recorded at 
very high levels in other parts of the country, such as the 
Purari Delta, Manus and urban Port Moresby.13 29
Inter-regional differences in NCD risks have been previ-
ously observed for hypercholesterolaemia. Some parts of 
the country inclusive of Asaro and rural Central Province 
recorded zero or low prevalence of hypercholestero-
laemia from the late 1980s to early 1990s,17 87 88 yet very 
high in certain populations such as urban Port Moresby 
and group of male miners in Bougainville.17 23 89 The prev-
alence of hypercholesterolaemia (24%) in our periurban 
West Hiri population was slightly lower than that of urban 
Port Moresby, although a lower cut-off (≥5.2 mmol/L) was 
used in the latter study. Our results combined with these 
previous studies suggest an urgent need for interventions 
to control CVD risk factors across all populations of PNG. 
In addition to WHO’s ‘best buys,’61 and a country appro-
priate  adaptation of the Green Prescription,90 enabling 
health education programmes to promote activity and 
healthy lifestyle in schools and communities would be 
beneficial for PNG.
Previous studies have reported a variable prevalence of 
DMT2 in parts of PNG. According to studies conducted 
in the 1980s–1990s, DMT2 was absent or existed at very 
low prevalence in many parts of PNG including Karkar 
Island and Asaro communities.33 34 54 DMT2 prevalences 
in these communities have remained low over a long 
period of time and our findings are consistent with the 
earlier studies; however, prediabetes data from our study 
may suggest this is changing. Indeed, studies conducted 
in Koki, in urban Port Moresby, Wanigela village in 
Central Province and residents of Port Moresby between 
the 1970s and 2000 reported very high prevalences of 
DMT2.16 18 31 32 Based on genetics and longer exposure to 
modernisation, it is not surprising that West Hiri popula-
tion had a higher prevalence of both prediabetes (26%) 
and DMT2 (9%) than Asaro and Karkar. Together with 
previous studies, our findings indicate limited change in 
DMT2 in recent history but continued marked disparity 
between populations, although the percentage of adults 
with elevated HbA1c across sites should be of significant 
concern. Control measures should include restrictions 
on imported high-sugar and fat content foods as well as 
the use of mass media and other education and public 
awareness raising activities.
strengths And lIMItAtIons
The study had a number of strengths and limitations. 
Strengths include an up-to-date prevalence of NCD risk 
factors in three sites at different stages of social and 
economic development; and the collection of NCD risk 
factor data during the early stages of a huge gas devel-
opment project which provides a baseline for future 
longitudinal studies to monitor NCDs and risk factors. 
The limitations are as follows: First, this was a cross-sec-
tional study and provides a snapshot of the risk and 
disease burden at a particular moment in time. Second, 
the study was conducted in only three locations across 
PNG and is therefore not nationally representative. Third, 
the full sample size was not achieved and younger people 
were undersampled, which could have led to an overes-
timation of NCD risk factor burden. Fourth, the study 
relied on the participants’ self-report for some measures, 
possibly resulting in recall bias (eg, self-reported 7-day 
food consumption). Fifth, biological samples were not 
collected from all participants therefore interpretation of 
results was limited only to those with biological samples.
conclusIon
Although not nationally representative, our study is 
suggestive of a socioeconomic and nutrition transition 
being under way in all three sites, especially in periurban 
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West Hiri, which had a higher NCD risk factor burden 
compared with the rural sites. However, some risk factors 
were common across sites, suggesting these populations are 
at heightened risk of developing CVDs. Few participants 
had received an NCD diagnosis despite the high prev-
alence of NCD risk factors, suggesting that current NCD 
screening and prevention as well as treatment services are 
inadequate in the sites taking part in this study. Training on 
NCDs and their risk factors as well as appropriate lifestyle 
interventions need to be incorporated into existing health 
training curriculum. Such training would facilitate appro-
priate screening, monitoring and control of NCDs at the 
primary healthcare setting. In addition, facilities need to 
be provided with the basic equipment/tools for screening. 
This calls for an urgent need to mobilise appropriate and 
multisectoral preventive interventions and upskill health 
services. Regular monitoring of these populations would 
provide up-to-date information and feedback on the 
effectiveness of any interventions for the emerging NCD 
epidemic in PNG.
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